CXCL9: A Potential Drug Target and Biomarker (G4283)

Target Name: CXCL9

NCBI ID: G4283

CXCL9

CXCL9: A Potential Drug Target and Biomarker

CXCL9, also known as interferon-gamma-induced monokine, is a protein that plays a critical role in the regulation of cell signaling pathways. It is a cytokine that is produced by various cell types in response to interferon-gamma, which is a signaling molecule that is derived from the immune response. Monokines are proteins that can stimulate the production of other proteins, and CXCL9 is one of the most well-studied monokines.

CXCL9 has been shown to have a variety of functions, including promoting cell survival, regulating cell proliferation, and participating in the immune response. It is also a potent drug target and has the potential to be used as a biomarker for various diseases. In this article, we will discuss the biology of CXCL9 and its potential as a drug target and biomarker.

The Biology of CXCL9

CXCL9 is a cytokine that is produced by various cell types in response to interferon-gamma. It is a single-chain protein that consists of 254 amino acids. It has a molecular weight of 31 kDa and a calculated pI of 6.5. CXCL9 is expressed in many different tissues and cells, including immune cells, epithelial cells, and fibroblasts.

One of the well-studied functions of CXCL9 is its role in the regulation of cell signaling pathways. It is a potent activator of the protein kinase AXL, which is a critical regulator of cell growth and survival. AXL is also known as the transcription factor p300, and it is involved in the regulation of many different genes.

In addition to its role in cell signaling, CXCL9 is also involved in the regulation of cell adhesion. It is a member of the Integrin alpha-6 (Integrin-伪6) complex, which is responsible for the adhesion of cells to various surfaces. CXCL9 has been shown to play a critical role in the regulation of cell adhesion, and it is involved in the development of cancer.

CXCL9 is also involved in the regulation of cell proliferation. It is a potent activator of the protein kinase B-cell src/FAK, which is involved in the regulation of cell proliferation. CXCL9 has been shown to play a critical role in the regulation of B cell proliferation, and it is involved in the development of many different types of cancer.

In addition to its role in cell signaling and proliferation, CXCL9 is also involved in the regulation of the immune response. It is a potent activator of the T-cell receptor, which is responsible for the regulation of immune cell function. CXCL9 has been shown to play a critical role in the regulation of T-cell receptor function, and it is involved in the development of many different types of cancer.

Potential Drug Target

CXCL9 has the potential to be a drug target due to its various functions. Its ability to activate the protein kinase AXL and regulate cell signaling pathways makes it a potential target for small molecules. Additionally, its role in the regulation of cell adhesion and proliferation make it a potential target for drugs that are capable of inhibiting cell adhesion or proliferation.

CXCL9 has also been shown to play a critical role in the regulation of the immune response, which makes it a potential target for drugs that are capable of modulating the immune response. Additionally, its role in the regulation of cell signaling pathways makes it a potential target for drugs that are capable of modulating cell signaling pathways.

Biomarker Potential

CXCL9 has the potential to be used as a biomarker for various diseases. Its role in the regulation of cell signaling pathways makes it a potential target for drugs that are capable of modulating cell signaling pathways. Additionally, its role in the regulation of cell adhesion and proliferation makes it a potential

Protein Name: C-X-C Motif Chemokine Ligand 9

Functions: Cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response. Chemotactic for activated T-cells. Binds to CXCR3

The "CXCL9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CXCL9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets